This section is taken from the 1992 edition of The Broad Range of Clinical Use of Phenytoin, published by the Dreyfus Medical Foundation, and over 500 more studies and references that have been collated since 1992 by the Dreyfus Health Foundation. For over thirty-five years, the Dreyfus Medical Foundation has conducted, sponsored, and researched studies on the usefulness or otherwise of phenytoin (Dilantin). For more information on the Dreyfus Medical Foundation, the story of Jack Dreyfus and the search for Dilantin, please go to the relevant sections on this site.

This section consists of the clinical uses of phenytoin and the basic mechanisms of action of phenytoin. It contains all of the studies that have shown phenytoin to be useful or otherwise for a wide variety of conditions. To navigate this site, you may search by condition or by study. This section also contains all 3100 references to the studies that have been conducted on phenytoin from the late 1930s to the early 1990s.

Terminology
The drug that is the subject of this book is known by two generic names, diphenylhydantoin and phenytoin. Phenytoin (PHT) is used in this book. PHT’s best known trade name in the United States is Dilantin. Other trade names, outside the United States, include Aleviaton, Dintoina, Epamin, Epanutin, Epelin, Eptoin, Hidantal, Idantoin, Phenhydan, Solantyl.

Prescription Medicine
PHT is a prescription medicine, which means it should be obtained through a physician. It is essential to note that no information contained on this site should be used outside consultation with your health care professional. Please read the advisory before proceeding.

It is essential to note that no information contained on this site should be used outside consultation with your health care professional. Please read the advisory before proceeding.

Click here for the Contents of the Broad Range of Clinical Use of Phenytoin